Should Stock Investors Buy and Hold Forever?

07:08pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
The pros and cons of buying a bunch of blue-chip stocks and holding them for 20+ years.

Spero (SPRO) Up Following Positive FDA Update for UTI Drug

02:36pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Spero (SPRO) surges on achieving common ground with the FDA on the regulatory path forward for tebipenem HBr.

Why Novavax Stock Sank to a New 52-Week Low Today

04:35pm, Tuesday, 06'th Sep 2022 The Motley Fool
The vaccine maker's recent regulatory victories aren't landing with investors.

Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?

10:20am, Tuesday, 06'th Sep 2022 Zacks Investment Research
Sector ETF report for XLV

Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland

05:08pm, Monday, 05'th Sep 2022 Zacks Investment Research
Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.

2 Top Trends to Invest $2,000 in Ahead of the Crowd

02:45pm, Monday, 05'th Sep 2022 The Motley Fool
These two trends on the frontier of medicine could present lucrative opportunities for investment.

Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?

01:00pm, Monday, 05'th Sep 2022 Zacks Investment Research
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms.

How To Replace 3M Company In Your Portfolio

09:35am, Saturday, 03'rd Sep 2022 Seeking Alpha
I offer replacements that offer comparable attributes to why investors choose 3M Company. Click here to see the list of potential replacements.

Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation

05:45pm, Friday, 02'nd Sep 2022 Zacks Investment Research
The European Medicines Agency's CHMP recommends expanded conditional marketing authorization for Novavax's (NVAX) COVID-19 vaccine as a booster for adults.

Is Veeva Systems Stock a Buy Now?

03:15pm, Friday, 02'nd Sep 2022 The Motley Fool
The cloud-based life sciences CRM provider faces a tough slowdown.

Novo Nordisk (NVO) to Tap Into SCD Space With Forma Acquisition

02:09pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Novo Nordisk (NVO) inks agreement to acquire Forma Therapeutics for $1.1 billion. The company is looking to venture into the sickle cell disease and rare blood disorders space.

PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion

01:06pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.

The Zacks Analyst Blog Highlights Pfizer /BioNTec and Moderna's

11:59am, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer /BioNTec and Moderna are part of The Zacks top Analyst Blog.

Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?

10:20am, Friday, 02'nd Sep 2022 Zacks Investment Research
Smart Beta ETF report for DHS
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE